• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 54-68 of 1,261 results

25 Motion Other: Apotexs Motion to Expunge

Document IPR2024-00631, No. 25 Motion Other - Apotexs Motion to Expunge (P.T.A.B. Nov. 15, 2024)

cite Cite Document
Analyze

11 Order Other: SCHEDULING ORDER

Document IPR2023-00724, No. 11 Order Other - SCHEDULING ORDER (P.T.A.B. Oct. 4, 2023)

cite Cite Document
Analyze

10 Institution Decision Grant: Institution Decision Grant

Document IPR2023-00724, No. 10 Institution Decision Grant - Institution Decision Grant (P.T.A.B. Oct. 4, 2023)

cite Cite Document
Analyze

20 Motion Other: Patent Owners Motion to Seal

Document IPR2024-00631, No. 20 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Jul. 15, 2024)

cite Cite Document
Analyze

14 Motion Other: Patent Owners Motion to Seal

Document IPR2024-00631, No. 14 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Jun. 12, 2024)

cite Cite Document
Analyze

5 Notice Notice filing date accorded: Notice Notice filing date accorded

Document IPR2023-00724, No. 5 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Apr. 6, 2023)

cite Cite Document
Analyze

96 Motion Other: Patent Owners Motion to Seal

Document IPR2023-00724, No. 96 Motion Other - Patent Owners Motion to Seal (P.T.A.B. Sep. 4, 2024)

cite Cite Document
Analyze

97 Motion Other: Petitioners Motion to Seal

Document IPR2023-00724, No. 97 Motion Other - Petitioners Motion to Seal (P.T.A.B. Sep. 4, 2024)

cite Cite Document
Analyze

No. 29

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 29 (N.D.W.Va. May. 19, 2022)

cite Cite Document
Analyze

No. 28

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 28 (N.D.W.Va. May. 19, 2022)

cite Cite Document
Analyze

11 Motion Other: Apotexs Motion to Seal

Document IPR2024-00631, No. 11 Motion Other - Apotexs Motion to Seal (P.T.A.B. Apr. 15, 2024)

cite Cite Document
Analyze

No. 23

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23 (N.D.W.Va. May. 9, 2022)

cite Cite Document
Analyze

83 Opposition: Petitioners Sun and DRLs joint Response to Patent Owner’s motion...

Document IPR2023-00724, No. 83 Opposition - Petitioners Sun and DRLs joint Response to Patent Owner’s motion for additional discovery (P.T.A.B. Aug. 19, 2024)

cite Cite Document
Analyze

82 Opposition: Petitioners Sun and DRLs joint opposition to Patent Owners motion ...

Document IPR2023-00724, No. 82 Opposition - Petitioners Sun and DRLs joint opposition to Patent Owners motion for sanctions (P.T.A.B. Aug. 19, 2024)

cite Cite Document
Analyze

80 Opposition: Mylans Opposition to POs Motion for Sanctions

Document IPR2023-00724, No. 80 Opposition - Mylans Opposition to POs Motion for Sanctions (P.T.A.B. Aug. 16, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 ... >>